NCT06696118View on ClinicalTrials.gov

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions
Osteoarthritis AnkleOsteoarthritis Foot
Interventions
DEVICE

Electromagnetic Transduction Therapy (EMTT)

Subjects will be treated with Electromagnetic Transduction Therapy (EMTT) using the Curamedix MAGNETOLITH device. Treatments will be administered twice per week, for four weeks. Each treatment will have the following settings: level 8, 8Hz, and 10,000 pulses andwill take about 15 to 20 minutes. Treatments will be spaced 2-3 days apart.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06696118 - Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle | Biotech Hunter | Biotech Hunter